Becton Dickinson Long Term Debt 2012-2026 | BDX
Becton Dickinson long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Becton Dickinson long term debt for the quarter ending March 31, 2026 was $16.916B, a 3% decline year-over-year.
- Becton Dickinson long term debt for 2025 was $17.621B, a 1.78% decline from 2024.
- Becton Dickinson long term debt for 2024 was $17.94B, a 21.73% increase from 2023.
- Becton Dickinson long term debt for 2023 was $14.738B, a 6.14% increase from 2022.
|
Becton Dickinson Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $17,621 |
| 2024 | $17,940 |
| 2023 | $14,738 |
| 2022 | $13,886 |
| 2021 | $17,110 |
| 2020 | $17,224 |
| 2019 | $18,081 |
| 2018 | $18,894 |
| 2017 | $18,667 |
| 2016 | $10,550 |
| 2015 | $11,370 |
| 2014 | $3,768 |
| 2013 | $3,763 |
| 2012 | $3,761 |
| 2011 | $2,485 |
|
Becton Dickinson Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-12-31 | $16,916 |
| 2025-09-30 | $17,621 |
| 2025-06-30 | $17,531 |
| 2025-03-31 | $17,666 |
| 2024-12-31 | $17,440 |
| 2024-09-30 | $17,940 |
| 2024-06-30 | $18,131 |
| 2024-03-31 | $15,995 |
| 2023-12-31 | $14,094 |
| 2023-09-30 | $14,738 |
| 2023-06-30 | $14,926 |
| 2023-03-31 | $16,010 |
| 2022-12-31 | $14,268 |
| 2022-09-30 | $13,886 |
| 2022-06-30 | $14,683 |
| 2022-03-31 | $17,584 |
| 2021-12-31 | $16,360 |
| 2021-09-30 | $17,110 |
| 2021-06-30 | $15,700 |
| 2021-03-31 | $17,718 |
| 2020-12-31 | $16,082 |
| 2020-09-30 | $17,224 |
| 2020-06-30 | $17,090 |
| 2020-03-31 | $16,809 |
| 2019-12-31 | $16,949 |
| 2019-09-30 | $18,081 |
| 2019-06-30 | $18,016 |
| 2019-03-31 | $17,556 |
| 2018-12-31 | $17,817 |
| 2018-09-30 | $18,894 |
| 2018-06-30 | $20,350 |
| 2018-03-31 | $22,589 |
| 2017-12-31 | $22,095 |
| 2017-09-30 | $18,667 |
| 2017-06-30 | $18,563 |
| 2017-03-31 | $9,082 |
| 2016-12-31 | $9,043 |
| 2016-09-30 | $10,550 |
| 2016-06-30 | $10,561 |
| 2016-03-31 | $10,864 |
| 2015-12-31 | $10,858 |
| 2015-09-30 | $11,370 |
| 2015-06-30 | $11,367 |
| 2015-03-31 | $12,128 |
| 2014-12-31 | $9,940 |
| 2014-09-30 | $3,768 |
| 2014-06-30 | $3,768 |
| 2014-03-31 | $3,764 |
| 2013-12-31 | $3,764 |
| 2013-09-30 | $3,763 |
| 2013-06-30 | $3,763 |
| 2013-03-31 | $3,762 |
| 2012-12-31 | $3,762 |
| 2012-09-30 | $3,761 |
| 2012-06-30 | $3,761 |
| 2012-03-31 | $3,964 |
| 2011-12-31 | $3,972 |
| 2011-09-30 | $2,485 |
| 2011-06-30 | $2,485 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |